JINARC

This brand name is authorized in Austria, Australia, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug JINARC contains one active pharmaceutical ingredient (API):

1 Tolvaptan UNII 21G72T1950 - TOLVAPTAN

Tolvaptan is a selective vasopressin V2-receptor antagonist that specifically blocks the binding of arginine vasopressin (AVP) at the V2-receptor of the distal portions of the nephron. Tolvaptan affinity for the human V2-receptor is 1.8 times that of native AVP. Read about Tolvaptan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
JINARC Tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C03XA01	Tolvaptan	C Cardiovascular system → C03 Diuretics → C03X Other diuretics → C03XA Vasopressin antagonists
Discover more medicines within C03XA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11588X, 11593E, 11596H, 11597J, 11600M, 11602P, 12457P, 12460T, 12461W, 12462X
Country: CA	Health Products and Food Branch	Identifier(s): 02437503, 02437511, 02437538, 02491575, 02491583
Country: EE	Ravimiamet	Identifier(s): 1686551, 1686562, 1686573, 1686584, 1686607, 1686641, 1686652, 1686663, 1686674, 1686685, 1686696, 1686708, 1686719
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1151000001, 1151000003, 1151000007, 1151000010, 1151000013
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 069019, 111615, 582720
Country: FR	Base de données publique des médicaments	Identifier(s): 61666369, 63026453, 64598514, 66056341, 68174566
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 310164, 310167, 310577, 310580, 310582, 310585, 310596, 310603
Country: HK	Department of Health Drug Office	Identifier(s): 65098, 65099, 65100, 65101, 65102
Country: IE	Health Products Regulatory Authority	Identifier(s): 88940, 88941, 88942, 88943, 88944
Country: IT	Agenzia del Farmaco	Identifier(s): 044202012, 044202024, 044202036, 044202048, 044202051, 044202063, 044202075, 044202087, 044202099, 044202101, 044202113, 044202125, 044202137, 044202149, 044202152, 044202164, 044202176, 044202188, 044202190, 044202202, 044202214, 044202226
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076760, 1076761, 1076762, 1076763, 1076764, 1076765, 1076766, 1076767, 1076768, 1076769, 1076770, 1076771, 1076772, 1086946, 1086947, 1086948, 1086949, 1086950, 1086951, 1086952, 1086953, 1086954
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 128228, 128236, 128279, 128287, 128295
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20038, 20058, 20059, 20060, 20061
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100347380, 100347410, 100347427, 100347440, 100347456
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66510001, W66511001, W66512001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680683010170, 8680683010187, 8680683010194, 8680683010200